Jason Wieboldt, Louis Atallah, Julia L

Slides:

Advertisements

Similar presentations

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Don B. Sanders, Huichuan J. Lai,

Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations

The prevalence of “risky behaviour” in adults with cystic fibrosis

Is infection with hypermutable Pseudomonas aeruginosa clinically significant? Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir

HbA1c as a screening tool for cystic fibrosis related diabetes

K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? Sarah P. Cohen, David M. Orenstein

Recurrent pulmonary exacerbations are associated with low fat free mass and low bone mineral density in young adults with cystic fibrosis Gianfranco.

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

Urinary incontinence in 9��16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group W.J. Browne, C.J. Wood, M.

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Cirrhosis and other liver disease in cystic fibrosis

Narelle S. Cox, Jennifer A. Alison, Brenda M. Button, John W

Delayed publication of clinical trials in cystic fibrosis

Controlled clinical trials in cystic fibrosis — are we doing better?

Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week- days during school term-time Rosemary Ball, Kevin W. Southern, Pamela.

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Cystic fibrosis mortality trend in Italy from 1970 to 2011

Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients Filip Van Ginderdeuren, Karlien Van Cauwelaert,

The Journal of Cystic Fibrosis: Sunny perspectives

Vitamin A and lung function in CF

Prenatal diagnosis for CF using High Resolution Melting Analysis and simultaneous haplotype analysis through QF-PCR Myrto Poulou, Aspasia Destouni, Georgia.

A.H. Gifford Journal of Cystic Fibrosis

Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis Elizabeth F. Shead, Charles S. Haworth,

Cystic fibrosis related diabetes in an extremely young patient

Inhalation solutions — Which ones may be mixed

Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C

Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India Shivaram S. Shastri, Madhulika Kabra, Sushil.

Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis Christopher R. Sudfeld, Elliott C. Dasenbrook, William.

Nasal polyposis in lung transplant recipients with cystic fibrosis

Narelle S. Cox, Jennifer Follett, Karen O. McKay

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Higher risk of hospitalization among females with cystic fibrosis

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis M.N. Hurley, A.H. Amin Ariff, C. Bertenshaw,

Lung clearance index during hospital admission in school-age children with cystic fibrosis Liam Welsh, Christopher Nesci, Haily Tran, Marisol Tomai,

Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids Francis J. Gilchrist, A.

V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume

Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency E.M. Bakker,

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Don B. Sanders, Huichuan J. Lai,

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid

Volume 146, Issue 4, Pages (October 2014)

Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R

V. Terlizzi, A. Tosco, R. Tomaiuolo, A. Sepe, N. Amato, A. Casale, C

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

CFTR modulators and pregnancy: Our work has only just begun

‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis

L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D

Beta-lactam allergy in adults with cystic fibrosis

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation Noa Nezer M. Sc, David Shoseyov, Eitan.

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995–2005 Donald R. VanDevanter, Eric P. Elkin,

Anne K. Swisher, Kathryn Moffett, Linda Baer

R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P

Presentation transcript:

Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis Jason Wieboldt, Louis Atallah, Julia L. Kelly, Dinesh Shrikrishna, Khin M. Gyi, Benny Lo, Guang Zhong Yang, Diana Bilton, Michael I. Polkey, Nicholas S. Hopkinson Journal of Cystic Fibrosis Volume 11, Issue 3, Pages 209-215 (May 2012) DOI: 10.1016/j.jcf.2011.12.001 Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Study flow chart. Journal of Cystic Fibrosis 2012 11, 209-215DOI: (10.1016/j.jcf.2011.12.001) Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Ear worn activity monitor (e-AR). Journal of Cystic Fibrosis 2012 11, 209-215DOI: (10.1016/j.jcf.2011.12.001) Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Quadriceps strength change over time. Quadriceps maximum voluntary contraction (QMVC) increased over time. Horizontal bars represent group means. Repeated measures ANOVA p<0.0001, admission vs discharge p=0.043; admission vs one month p=0.0003; discharge vs one month p=0.0009. Journal of Cystic Fibrosis 2012 11, 209-215DOI: (10.1016/j.jcf.2011.12.001) Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

Fig. 4 Energy expenditure from the Sensewear armband (METs) (Panel a) e-AR and the activity index (AI) from the e-AR monitor (b). The two measures correlated with the armband R 0.74 (p<0.0001) for this individual and R 0.64(0.1) (p<0.0001) for the whole group. Journal of Cystic Fibrosis 2012 11, 209-215DOI: (10.1016/j.jcf.2011.12.001) Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions